“…Two of the leading innovators in the field, Fish and Jaouen, recently summarized the core subjects that make up the field of bioorganometallic chemistry in a review published in Organometallics; 1 and a previous review on bioorganometallic chemistry that highlighted the potential of the subject is given by Jaouen et al 2 Various bioorganometallic topics have been identified, including the synthesis of biologically relevant compounds via catalysis or organometallic intermediates, catalytic action on biomolecules, the synthesis of organometallic compounds with biologically relevant co-ligands, organometallic Bioorganometallic Chemistry 44 and a second compound, ferrocifen, which is a ferrocene derivative of tamoxifen, 19,45 looks set to enter clinical trials in the near future (Jaouen G, personal communication). Main-group organometallic complexes are not listed in Table 1, although some compounds such as diorganotin(IV) derivatives have been known to have antiproliferative activity on specific cancers for many years.…”